Indianapolis-based Barnes & Thornburg LLP recently said it is growing its complex litigation and life sciences practices with the openings of new offices in New Jersey and Philadelphia, marking the firm’s latest expansion on the East Coast.
The Morristown and Philadelphia offices, its 21st and 22nd in the U.S., will serve the industries that are resident in that corridor, including life sciences, health care, consumer products and financial services.
The new offices are anchored by well-respected and nationally recognized product liability, mass tort and life sciences litigators and counselors Michael Zogby, Jessica Brennan and Kaitlyn Stone in New Jersey, and Chanda Miller, Molly Flynn and Rebecca Trela in Philadelphia.
Zogby will anchor both the New Jersey and Philadelphia offices as the partner-in-charge.
“New Jersey is recognized as the ‘medicine chest of the world’ for its world-renowned cluster of life sciences companies, while Philadelphia has long been one of the most attractive locations in the country for manufacturing, research & development, and international companies looking to establish operations in the states,” Andrew Detherage, Barnes & Thornburg’s managing partner-elect, said in a news release announcing the new locations. Detherage has been leading the firm’s strategic expansion.
“Given the importance of these markets to our life sciences and corporate clients, we’re thrilled to have this new team come on board to help us establish a first-rate presence in the region.”
The opening of the two offices is the latest East Coast expansion for Barnes and follows the opening of the firm’s Boston office and significant growth over the past two years in its Washington, D.C., and Delaware offices. The firm also opened its New York office in 2020, which has grown to 30 lawyers and staff, while adding life sciences-focused locations in North Carolina, Michigan and Salt Lake City in 2019.
“I have known and worked alongside Barnes & Thornburg litigators for almost two decades, and have always been impressed with their track record and trial reputation, and the collegial nature of the firm,” Zogby said in the news release. “We were attracted to the sophisticated nature and rapid growth of the firm’s health and life sciences practice, which boasts more than 200 practitioners located in leading life sciences and biotech hubs across the country. The firm’s platform is ideal for continuing to serve our clients at the highest level, and we look forward to collaborating with our new partners and colleagues.”
